Article
Circulating microRNA profile unveils mechanisms of action of acitretin for psoriasis vulgaris
1 Jan 2021
Abstract excerpt
Psoriasis vulgaris is a common chronic and recurrent inflammatory skin disease. In clinical practice, acitretin is the first-line treatment drug for psoriasis vulgaris. MicroRNAs (miRNAs) play a vital role in the initiation and development of psoriasis vulgaris. However few studies focused on the mechanisms of acitretin in the treatment of psoriasis vulgaris from the perspective of miRNAs. Here, the expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
